ProfileGDS4132 / 203005_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 73% 70% 78% 78% 71% 75% 76% 71% 81% 76% 82% 79% 78% 87% 78% 74% 78% 75% 74% 75% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101223.1173
GSM201543Muscle PCOS pioglitazone 121201.05670
GSM201544Muscle PCOS pioglitazone 161266.57878
GSM201545Muscle PCOS pioglitazone 201278.24178
GSM201829Muscle PCOS pioglitazone 231225.56871
GSM201830Muscle PCOS pioglitazon 251242.85475
GSM201831Muscle PCOS pioglitazone 271250.46676
GSM201832Muscle PCOS pioglitazone 31207.29371
GSM201833Muscle PCOS pioglitazone 41280.43181
GSM201834Muscle PCOS pioglitazone 81248.98976
GSM201835Muscle PCOS after pioglitazone 102294.30782
GSM201836Muscle PCOS after pioglitazone 122267.76979
GSM201837Muscle PCOS after pioglitazone 162247.8178
GSM201838Muscle PCOS after pioglitazone 202404.09187
GSM201839Muscle PCOS after pioglitazone 232267.24478
GSM201840Muscle PCOS after pioglitazone 252239.75774
GSM201841Muscle PCOS after pioglitazone 272246.52878
GSM201842Muscle PCOS after pioglitazone 32215.98875
GSM201843Muscle PCOS after pioglitazone 42226.14174
GSM201844Muscle PCOS after pioglitazone 82244.26175